MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023
NEWS RELEASE – REGULATED INFORMATION8 MARCH 2023, 4:00 PM EST / 22:00 CET Conference call…
Year: 2023
Xcitium Launches Zero Dwell – Trusted Security Advisory Community
BLOOMFIELD, N.J., March 08, 2023 (GLOBE NEWSWIRE) — Today, Xcitium, the cybersecurity industry’s leading provider…
Moovly Amends Warrant Terms to Extend Expiry Date
Vancouver, British Columbia–(Newsfile Corp. – March 8, 2023) – Moovly Media Inc. (TSXV: MVY) (OTCQB:…
Delaware Investments National Municipal Income Fund Announces Results of the Special Shareholder Meeting Relating to the Proposed New Investment Management Agreement with abrdn Inc. and Nomination of Four New Trustees
PHILADELPHIA–(BUSINESS WIRE)–Today, Delaware Investments National Municipal Income Fund (the “Fund”), a New York Stock Exchange…
CUNY’s Brooklyn College Selects YuJa Enterprise Video Platform to Serve More Than 15,000 Students Campuswide
SAN JOSE, Calif.–(BUSINESS WIRE)–Part of the City University of New York (CUNY), Brooklyn College has…
Welcome to the New Era of Experience Management: Qualtrics XM for Frontlines
Innovations across the world’s #1 XM Platform empower every frontline employee and supercharge the digital…
Powered by Experience iD, Qualtrics Frontline Innovations Bring Digital Behavioral Data Natively to the World’s Leading Experience Management Platform
New Customer Journey Optimizer combines behavior, experience and operational data in Qualtrics Experience iD to…
New Qualtrics Frontline Care Solutions Empower Customer Service Agents and Managers with Qualtrics AI and Real-Time Data
New Qualtrics Frontline Agent Coaching helps managers build stronger teams with automated coaching, so they…
CADTH Recommends Reimbursement for BioCryst’s ORLADEYO® (berotralstat) for the Routine Prevention of Attacks in Hereditary Angioedema Patients in Canada
INTENDED FOR CANADIAN AUDIENCES ONLY RESEARCH TRIANGLE PARK, N.C., March 08, 2023 (GLOBE NEWSWIRE) —…
NKGen Biotech Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Natural Killer Cell Therapies Targeting Neurodegenerative Diseases
SANTA ANA, Calif., March 08, 2023 (GLOBE NEWSWIRE) — NKGen Biotech, a biotechnology company harnessing…
Axiom Celebrates the Many Women in their Organization for International Women’s Day!
TORONTO, March 08, 2023 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of…
BetterLife Announces Pricing of Proposed Offering of Units
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British…
NTG Nordic Transport Group A/S – Notice to convene the Annual General Meeting 2023
Company announcement no. 7 – 23 8 March 2023 NTG Nordic Transport Group A/S –…
Springboard Selected as Education Partner for Walmart’s Live Better U™ Program
Online Learning Platform has Created over $1B in Earnings for Alumni and will Extend Its…
NTG Nordic Transport Group launches share buy-back program
Company announcement no. 6 – 23 8 March 2023 NTG Nordic Transport Group launches share…
NTG Nordic Transport Group launches share buy-back program
Company announcement no. 6 – 23 8 March 2023 NTG Nordic Transport Group launches share…
NTG Nordic Transport Group Annual Report for 2022
Company announcement no. 5 – 238 March 2023 NTG Nordic Transport Group Annual Report for…
NTG Nordic Transport Group Annual Report for 2022
Company announcement no. 5 – 238 March 2023 NTG Nordic Transport Group Annual Report for…
Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel (FYCOMPA®) Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies
CORAL GABLES, Fla., March 08, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
Catalyst Pharmaceuticals Announces a Recent Third-Party Publication in Peer-Reviewed Journal Epilepsia Showing Perampanel (FYCOMPA®) Demonstrated High Efficacy in Patients with Rare Genetic Epilepsies
CORAL GABLES, Fla., March 08, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…